MJUS News and Press, ETFMG U.S. Alternative Harvest ETF From 06/01/22

We can't control the markets. Investors need patience, more institutional capital and more catalysts, but mostly patience. Matt Hawkins returns to discuss StateHouse/Harborside, the California cannabis market and the developing US picture. Advice to retail investors and why managi...

Capital is disappearing in the cannabis industry. Mike Regan and Colin Ferrian return and we discuss what investors need to understand about valuations (it's not just like tech). Grading California's main players, consumption patterns, price erosion. EBIDA over EBITDA. For a r...

Dr. Robin Goldstein and Professor Daniel Sumner wrote Can Legal Weed Win?: The Blunt Realities of Cannabis Economics. Competition between legal and illicit market. The difference in states' timelines. What types of policies will help legal weed win, learning from other commodity m...

IIPR's selloff has continued and shares have nearly been cut in half YTD. Shares now yield 5.1%, which is absurd when you consider the dividend growth track record and potential future dividend growth. It currently trades near all-time low valuations, with shares below a 20x price...

Patience, more institutional capital and more catalysts, but mostly patience as we wait for the industry to grow into a more mature sector. Matt Hawkins returns to discuss StateHouse/Harborside, the California cannabis market and the developing US picture. Advice to retail investo...

The S&P 500 is off to its worst start since 1939, and the NASDAQ notched its worst opening quarter since launching in 1971. For cannabis stocks, it was the worst month since COVID-lows of March 2020. April was another month where equity markets sold off, and cannabis got hit harde...

Julian Lin catches us up on recent earnings volatility, valuations and how investors should be looking at the cannabis industry. Why he's a big fan of Verano but not a fan of the Cresco/Columbia Care merger. IIPR, NewLake Capital and why cannabis REITs are highly compelling. ...

Obstacles preventing banks from having a clear, professional relationship with marijuana companies remain. While federal legalization still faces hurdles, state-level momentum is projected to continue this year after an eventful 2021. An interesting trend to watch out for in 2022 ...

Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings in the cannabis space and why disappointment is overblown. Favoring quality, underappreciated names due to favorable fundamentals and growth opportunities. The interesting way institutional capital is ...

Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings and why disappointment is overblown. Favoring quality, underappreciated names in the cannabis industry due to favorable fundamentals and growth opportunities. These names also benefit from consolidatio...